Travere Therapeutics, Inc. - FORM 10-K - EX-21.1 - March 1, 2021

Attached files

file filename
EX-10.38 - EX-10.38 - Travere Therapeutics, Inc.ex1038-1231202010k.htm
EX-32.1 - EX-32.1 - Travere Therapeutics, Inc.ex321-1231202010k.htm
EX-32.2 - EX-32.2 - Travere Therapeutics, Inc.ex322-1231202010k.htm
10-K - 10-K - Travere Therapeutics, Inc.rtrx-20201231.htm
EX-31.1 - EX-31.1 - Travere Therapeutics, Inc.ex311-1231202010k.htm
EX-4.2 - EX-4.2 - Travere Therapeutics, Inc.ex42-1231202010k.htm
EX-31.2 - EX-31.2 - Travere Therapeutics, Inc.ex312-1231202010k.htm
EX-23.1 - EX-23.1 - Travere Therapeutics, Inc.ex231-1231202010k.htm

EX
Exhibit 21.1
TRAVERE THERAPEUTICS, INC.
LIST OF SUBSIDIARIES
No. 
 Name
1 Travere Therapeutics Pharmaceutical, Inc.
2 Travere Therapeutics Ireland Limited
3 Orphan Technologies Limited
4 Travere Therapeutics Research Ltd
5Travere Therapeutics US Holdings, LLC
6Kyalin Biosciences, Inc.
7Manchester Pharmaceuticals LLC
8Centurion Merger Sub, Inc.
9Centurion Intermediate Sub, Inc.


Travere Therapeutics, Inc. Reports